BRIEF-Seastar Medical Submits HDE Application For Use Of Selective Cytopheretic Device
Reuters
Jul 20, 2022
July 20 (Reuters) - SeaStar Medical:
* SEASTAR MEDICAL SUBMITS HUMANITARIAN DEVICE EXEMPTION APPLICATION TO FDA FOR USE OF SELECTIVE CYTOPHERETIC DEVICE IN CHILDREN WITH ACUTE KIDNEY INJURY
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.